메뉴 건너뛰기




Volumn 15, Issue 4, 2012, Pages 348-357

Clinical characteristics of 150 consecutive fibromyalgia patients attending an Australian public hospital clinic

Author keywords

Australian population; Fibromyalgia characteristics

Indexed keywords

DULOXETINE; PREGABALIN; TRICYCLIC ANTIDEPRESSANT AGENT;

EID: 84865300081     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2012.01767.x     Document Type: Article
Times cited : (16)

References (42)
  • 1
    • 0034776337 scopus 로고    scopus 로고
    • The burden of musculoskeletal diseases in the general population of Spain: results from a national survey
    • Carmona L, Ballina J, Gabriel R, Laffon A (2001) The burden of musculoskeletal diseases in the general population of Spain: results from a national survey. Ann Rheum Dis 60, 1040-5.
    • (2001) Ann Rheum Dis , vol.60 , pp. 1040-1045
    • Carmona, L.1    Ballina, J.2    Gabriel, R.3    Laffon, A.4
  • 2
    • 0033056393 scopus 로고    scopus 로고
    • The London Fibromyalgia Epidemiology Study: comparing the demographic and clinical characteristics in 100 random community cases of fibromyalgia versus controls
    • White KP, Speechley M, Harth M, Ostbye T (1999) The London Fibromyalgia Epidemiology Study: comparing the demographic and clinical characteristics in 100 random community cases of fibromyalgia versus controls. J Rheumatol 26, 1577-85.
    • (1999) J Rheumatol , vol.26 , pp. 1577-1585
    • White, K.P.1    Speechley, M.2    Harth, M.3    Ostbye, T.4
  • 3
    • 0028890678 scopus 로고
    • The prevalence and characteristics of fibromyalgia in the general population
    • Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L (1995) The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38, 19-28.
    • (1995) Arthritis Rheum , vol.38 , pp. 19-28
    • Wolfe, F.1    Ross, K.2    Anderson, J.3    Russell, I.J.4    Hebert, L.5
  • 4
    • 37349047023 scopus 로고    scopus 로고
    • The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12
    • Hoffman DL, Dukes EM (2008) The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12. Int J Clin Pract 62, 115-26.
    • (2008) Int J Clin Pract , vol.62 , pp. 115-126
    • Hoffman, D.L.1    Dukes, E.M.2
  • 5
    • 34547754495 scopus 로고    scopus 로고
    • Characteristics and healthcare costs of patients with fibromyalgia syndrome
    • Berger A, Dukes E, Martin S, Edelsberg J, Oster G (2007) Characteristics and healthcare costs of patients with fibromyalgia syndrome. Int J Clin Pract 61, 1498-508.
    • (2007) Int J Clin Pract , vol.61 , pp. 1498-1508
    • Berger, A.1    Dukes, E.2    Martin, S.3    Edelsberg, J.4    Oster, G.5
  • 6
    • 0025266660 scopus 로고
    • The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee
    • Wolfe F, Smythe HA, Yunus MB, et al. (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33, 160-72.
    • (1990) Arthritis Rheum , vol.33 , pp. 160-172
    • Wolfe, F.1    Smythe, H.A.2    Yunus, M.B.3
  • 8
    • 0032910403 scopus 로고    scopus 로고
    • Emerging concepts in the neurobiology of chronic pain: evidence of abnormal sensory processing in fibromyalgia
    • Bennett RM (1999) Emerging concepts in the neurobiology of chronic pain: evidence of abnormal sensory processing in fibromyalgia. Mayo Clin Proc 74, 385-98.
    • (1999) Mayo Clin Proc , vol.74 , pp. 385-398
    • Bennett, R.M.1
  • 9
    • 0036672993 scopus 로고    scopus 로고
    • Evidence of involvement of central neural mechanisms in generating fibromyalgia pain
    • Staud R (2002) Evidence of involvement of central neural mechanisms in generating fibromyalgia pain. Curr Rheumatol Rep 4, 299-305.
    • (2002) Curr Rheumatol Rep , vol.4 , pp. 299-305
    • Staud, R.1
  • 12
    • 19944427292 scopus 로고    scopus 로고
    • Genetic basis for individual variations in pain perception and the development of a chronic pain condition
    • Diatchenko L, Slade GD, Nackley AG, et al. (2005) Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet 14, 135-43.
    • (2005) Hum Mol Genet , vol.14 , pp. 135-143
    • Diatchenko, L.1    Slade, G.D.2    Nackley, A.G.3
  • 13
    • 0032726813 scopus 로고    scopus 로고
    • The T102C polymorphism of the 5-HT2A-receptor gene in fibromyalgia
    • Bondy B, Spaeth M, Offenbaecher M et al. (1999) The T102C polymorphism of the 5-HT2A-receptor gene in fibromyalgia. Neurobiol Dis 6, 433-9.
    • (1999) Neurobiol Dis , vol.6 , pp. 433-439
    • Bondy, B.1    Spaeth, M.2    Offenbaecher, M.3
  • 14
    • 0038512578 scopus 로고    scopus 로고
    • Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome
    • Gursoy S, Erdal E, Herken H, Madenci E, Alasehirli B, Erdal N (2003) Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatol Int 23, 104-7.
    • (2003) Rheumatol Int , vol.23 , pp. 104-107
    • Gursoy, S.1    Erdal, E.2    Herken, H.3    Madenci, E.4    Alasehirli, B.5    Erdal, N.6
  • 15
    • 4243165660 scopus 로고    scopus 로고
    • An association between fibromyalgia and the dopamine D4 receptor exon III repeat polymorphism and relationship to novelty seeking personality traits
    • Buskila D, Cohen H, Neumann L, Ebstein RP (2004) An association between fibromyalgia and the dopamine D4 receptor exon III repeat polymorphism and relationship to novelty seeking personality traits. Mol Psychiatry 9, 730-1.
    • (2004) Mol Psychiatry , vol.9 , pp. 730-731
    • Buskila, D.1    Cohen, H.2    Neumann, L.3    Ebstein, R.P.4
  • 16
    • 84865287593 scopus 로고    scopus 로고
    • Gender, genetics, and other risk factors increasing vulnerability to fibromyalgia
    • In: Mense S, RD (ed.), Springer-Verlag, Berlin Heidelberg.
    • Littlejohn GO (2010) Gender, genetics, and other risk factors increasing vulnerability to fibromyalgia. In: Mense S, RD (ed.) Muscle Pain: Diagnosis and Treatment, pp 143-57. Springer-Verlag, Berlin Heidelberg.
    • (2010) Muscle Pain: Diagnosis and Treatment , pp. 143-157
    • Littlejohn, G.O.1
  • 17
    • 0034117292 scopus 로고    scopus 로고
    • Antidepressant treatment of fibromyalgia. A meta-analysis and review
    • Arnold LM, Keck PE Jr, Welge JA (2000) Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics 41, 104-13.
    • (2000) Psychosomatics , vol.41 , pp. 104-113
    • Arnold, L.M.1    Keck Jr, P.E.2    Welge, J.A.3
  • 18
    • 4444381930 scopus 로고    scopus 로고
    • A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder
    • Arnold LM, Lu Y, Crofford LJ et al. (2004) A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 50, 2974-84.
    • (2004) Arthritis Rheum , vol.50 , pp. 2974-2984
    • Arnold, L.M.1    Lu, Y.2    Crofford, L.J.3
  • 19
    • 43549091316 scopus 로고    scopus 로고
    • Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial
    • Russell IJ, Mease PJ, Smith TR et al. (2008) Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain 136, 432-44.
    • (2008) Pain , vol.136 , pp. 432-444
    • Russell, I.J.1    Mease, P.J.2    Smith, T.R.3
  • 20
    • 57649234533 scopus 로고    scopus 로고
    • Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial
    • Clauw DJ, Mease P, Palmer RH, Gendreau RM, Wang Y (2008) Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clin Ther 30, 1988-2004.
    • (2008) Clin Ther , vol.30 , pp. 1988-2004
    • Clauw, D.J.1    Mease, P.2    Palmer, R.H.3    Gendreau, R.M.4    Wang, Y.5
  • 21
    • 64849117499 scopus 로고    scopus 로고
    • The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial
    • Mease PJ, Clauw DJ, Gendreau RM et al. (2009) The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial. J Rheumatol 36, 398-409.
    • (2009) J Rheumatol , vol.36 , pp. 398-409
    • Mease, P.J.1    Clauw, D.J.2    Gendreau, R.M.3
  • 22
    • 40649095921 scopus 로고    scopus 로고
    • A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia
    • Mease PJ, Russell IJ, Arnold LM et al. (2008) A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. J Rheumatol 35, 502-14.
    • (2008) J Rheumatol , vol.35 , pp. 502-514
    • Mease, P.J.1    Russell, I.J.2    Arnold, L.M.3
  • 23
    • 20244389715 scopus 로고    scopus 로고
    • Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial
    • Crofford LJ, Rowbotham MC, Mease PJ et al. (2005) Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 52, 1264-73.
    • (2005) Arthritis Rheum , vol.52 , pp. 1264-1273
    • Crofford, L.J.1    Rowbotham, M.C.2    Mease, P.J.3
  • 24
    • 43549104210 scopus 로고    scopus 로고
    • Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin
    • Crofford LJ, Mease PJ, Simpson SL et al. (2008) Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin. Pain 136, 419-31.
    • (2008) Pain , vol.136 , pp. 419-431
    • Crofford, L.J.1    Mease, P.J.2    Simpson, S.L.3
  • 26
    • 0032877246 scopus 로고    scopus 로고
    • A meta-analysis of fibromyalgia treatment interventions
    • Rossy LA, Buckelew SP, Dorr N et al. (1999) A meta-analysis of fibromyalgia treatment interventions. Ann Behav Med 21, 180-91.
    • (1999) Ann Behav Med , vol.21 , pp. 180-191
    • Rossy, L.A.1    Buckelew, S.P.2    Dorr, N.3
  • 28
    • 0035990310 scopus 로고    scopus 로고
    • Improving physical functional status in patients with fibromyalgia: a brief cognitive behavioral intervention
    • Williams DA, Cary MA, Groner KH et al. (2002) Improving physical functional status in patients with fibromyalgia: a brief cognitive behavioral intervention. J Rheumatol 29, 1280-6.
    • (2002) J Rheumatol , vol.29 , pp. 1280-1286
    • Williams, D.A.1    Cary, M.A.2    Groner, K.H.3
  • 29
    • 34250673528 scopus 로고    scopus 로고
    • Responder criteria for operant and cognitive-behavioral treatment of fibromyalgia syndrome
    • Thieme K, Turk DC, Flor H (2007) Responder criteria for operant and cognitive-behavioral treatment of fibromyalgia syndrome. Arthritis Rheum 57, 830-6.
    • (2007) Arthritis Rheum , vol.57 , pp. 830-836
    • Thieme, K.1    Turk, D.C.2    Flor, H.3
  • 30
    • 84873007880 scopus 로고    scopus 로고
    • Australian Institute of Health and Welfare website. Table S13:Selected health conditions by disability status and age group, Australia, 2007-08 (percent). Australian Institute of Health and Welfare website, Australian Government, 2010 (Accessed 11 December 2010).
    • Australian Institute of Health and Welfare website. Table S13:Selected health conditions by disability status and age group, Australia, 2007-08 (percent). Australian Institute of Health and Welfare website, Australian Government, 2010 (Accessed 11 December 2010).
  • 31
    • 0026165648 scopus 로고
    • The fibromyalgia impact questionnaire: development and validation
    • Burckhardt CS, Clark SR, Bennett RM (1991) The fibromyalgia impact questionnaire: development and validation. J Rheumatol 18, 728-33.
    • (1991) J Rheumatol , vol.18 , pp. 728-733
    • Burckhardt, C.S.1    Clark, S.R.2    Bennett, R.M.3
  • 32
    • 33644807054 scopus 로고    scopus 로고
    • The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses
    • Bennett R (2005) The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol 23, S154-62.
    • (2005) Clin Exp Rheumatol , vol.23
    • Bennett, R.1
  • 33
    • 77951735184 scopus 로고    scopus 로고
    • The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity
    • Wolfe F, Clauw DJ, Fitzcharles MA et al. (2010) The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 62, 600-10.
    • (2010) Arthritis Care Res (Hoboken) , vol.62 , pp. 600-610
    • Wolfe, F.1    Clauw, D.J.2    Fitzcharles, M.A.3
  • 34
    • 0028868197 scopus 로고
    • Aspects of fibromyalgia in the general population: sex, pain threshold, and fibromyalgia symptoms
    • Wolfe F, Ross K, Anderson J, Russell IJ (1995) Aspects of fibromyalgia in the general population: sex, pain threshold, and fibromyalgia symptoms. J Rheumatol 22, 151-6.
    • (1995) J Rheumatol , vol.22 , pp. 151-156
    • Wolfe, F.1    Ross, K.2    Anderson, J.3    Russell, I.J.4
  • 35
    • 79957809749 scopus 로고    scopus 로고
    • Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia
    • Wolfe F, Clauw DJ, Fitzcharles MA et al. (2011) Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia. J Rheumatol 38, 1113-22.
    • (2011) J Rheumatol , vol.38 , pp. 1113-1122
    • Wolfe, F.1    Clauw, D.J.2    Fitzcharles, M.A.3
  • 36
    • 0036171047 scopus 로고    scopus 로고
    • The effects of progressive strength training and aerobic exercise on muscle strength and cardiovascular fitness in women with fibromyalgia: a pilot study
    • Rooks DS, Silverman CB, Kantrowitz FG (2002) The effects of progressive strength training and aerobic exercise on muscle strength and cardiovascular fitness in women with fibromyalgia: a pilot study. Arthritis Rheum 47, 22-8.
    • (2002) Arthritis Rheum , vol.47 , pp. 22-28
    • Rooks, D.S.1    Silverman, C.B.2    Kantrowitz, F.G.3
  • 37
    • 0028230135 scopus 로고
    • A randomized, controlled clinical trial of education and physical training for women with fibromyalgia
    • Burckhardt CS, Mannerkorpi K, Hedenberg L, Bjelle A (1994) A randomized, controlled clinical trial of education and physical training for women with fibromyalgia. J Rheumatol 21, 714-20.
    • (1994) J Rheumatol , vol.21 , pp. 714-720
    • Burckhardt, C.S.1    Mannerkorpi, K.2    Hedenberg, L.3    Bjelle, A.4
  • 38
    • 33744826519 scopus 로고    scopus 로고
    • Improvement in fibromyalgia symptoms with acupuncture: results of a randomized controlled trial
    • Martin DP, Sletten CD, Williams BA, Berger IH (2006) Improvement in fibromyalgia symptoms with acupuncture: results of a randomized controlled trial. Mayo Clin Proc 81, 749-57.
    • (2006) Mayo Clin Proc , vol.81 , pp. 749-757
    • Martin, D.P.1    Sletten, C.D.2    Williams, B.A.3    Berger, I.H.4
  • 39
    • 0037716856 scopus 로고    scopus 로고
    • Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study
    • Bennett RM, Kamin M, Karim R, Rosenthal N (2003) Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study. Am J Med 114, 537-45.
    • (2003) Am J Med , vol.114 , pp. 537-545
    • Bennett, R.M.1    Kamin, M.2    Karim, R.3    Rosenthal, N.4
  • 41
    • 50649110564 scopus 로고    scopus 로고
    • Psychological pain treatment in fibromyalgia syndrome: efficacy of operant behavioural and cognitive behavioural treatments
    • Thieme K, Flor H, Turk DC (2006) Psychological pain treatment in fibromyalgia syndrome: efficacy of operant behavioural and cognitive behavioural treatments. Arthritis Res Ther 8, R121.
    • (2006) Arthritis Res Ther , vol.8
    • Thieme, K.1    Flor, H.2    Turk, D.C.3
  • 42
    • 77953941540 scopus 로고    scopus 로고
    • Identification of symptom and functional domains that fibromyalgia patients would like to see improved: a cluster analysis
    • Bennett RM, Russell J, Cappelleri JC, Bushmakin AG, Zlateva G, Sadosky A (2010) Identification of symptom and functional domains that fibromyalgia patients would like to see improved: a cluster analysis. BMC Musculoskelet Disord 11, 134.
    • (2010) BMC Musculoskelet Disord , vol.11 , pp. 134
    • Bennett, R.M.1    Russell, J.2    Cappelleri, J.C.3    Bushmakin, A.G.4    Zlateva, G.5    Sadosky, A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.